ArticleNeuroradiology2026
Symptomatic cerebral venous outflow resistance responds to stenting even in the absence of intracranial hypertension on manometry: a multicentre study.
Article in Neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe relative contribution of venous outflow obstruction and intracranial pressure (ICP) to symptomatology and treatment response in Idiopathic Intracranial Hypertension (IIH) remains uncertain. Venous sinus stenting (VSS) is indicated in patients with significant trans-stenotic pressure gradients (TPG) and concordant symptoms. A subset of these patients demonstrates conventionally normal superior sagittal sinus (SSS) pressures. As SSS pressure is often interpreted as a surrogate for ICP, it remains uncertain whether these patients derive benefit from VSS.
methodsA multicentre VSS registry was retrospectively queried to identify IIH patients with normal SSS pressure (≤ 15 mmHg). These patients were matched 1:1 to patients with elevated SSS pressure (> 15 mmHg) based on pre-stent TPG. Primary outcomes were improvement in headache, tinnitus and papilledema. Multivariable regression assessed the association between SSS pressure and clinical outcomes, adjusting for residual differences in pre-stent TPG.
resultsAmong 517 patients undergoing VSS, 33 (6.4%) were eligible for inclusion in the normal SSS pressure cohort (median 12.0 mmHg) and matched to 33 patients with elevated SSS pressures (median 20.0 mmHg). Despite matching, median pre-stent TPG remained lower in the normal SSS group (6.0 vs. 8.0 mmHg, p < 0.01). Rates of headache, papilledema and tinnitus improvement were comparable between groups (82.8% vs. 69.7%, 90.9% vs. 77.3%, and 78.3% vs. 84.6%, respectively). After adjustment for TPG, SSS pressure was not associated with clinical outcomes.
conclusionVSS appears beneficial even in the absence of intracranial hypertension on manometry. These findings support the relevance of venous outflow resistance in guiding stenting decisions.
Indexed as
Identifiers
42684436What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.